Noncoding RNA regulation of dopamine signaling in diseases of the central nervous system
Dopaminergic neurotransmission mediates a majority of the vital central nervous system functions. Disruption of these synaptic events provokes a multitude of neurological pathologies, including Parkinson’s, schizophrenia, depression and addiction. Growing evidence supports a key role for noncoding R...
Main Authors: | William Carrick, Brandi Burks, Murray Cairns, Jannet Kocerha |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-10-01
|
Series: | Frontiers in Molecular Biosciences |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fmolb.2016.00069/full |
Similar Items
-
Advances in noncoding RNA profiling for neurological diseases
by: Murray eCairns, et al.
Published: (2013-01-01) -
Novel Insights into the Role of Long Noncoding RNA in Ocular Diseases
by: Fang Li, et al.
Published: (2016-03-01) -
Understanding the interplay between N6‐methyladenine RNA methylation and noncoding RNAs in kidney disease
by: Saiya Zhu, et al.
Published: (2023-10-01) -
RNA Deregulation in Amyotrophic Lateral Sclerosis: The Noncoding Perspective
by: Pietro Laneve, et al.
Published: (2021-09-01) -
The role of tyrosine hydroxylase-dopamine pathway in Parkinson's disease pathogenesis
by: Zhou, Zhi Dong, et al.
Published: (2023)